ArticleOman medical journal2025
Circulating Red Cell and Platelet Microparticles in Pediatric Non-transfusion Dependent Beta-thalassemia: A Case Control Study.
Article in Oman medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate the levels of circulating erythrocyte-derived microparticles (EMPs) and platelet-derived microparticles (PMPs)in children with non-transfusion-dependent beta-thalassemia (NTDT), and explore their contribution to hypercoagulability. Methods: This case-control study included 50 children diagnosed with NTDT and 50 age- and sex-matched healthy controls. The children were recruited from the hematology/oncology unit of Alexandria University Children's Hospital, Egypt from November 2022 to May 2023. Results: The percentage of EMPs and PMPs was significantly higher in NTDT patients compared with healthy controls. Serum B-type natriuretic peptide was higher in NTDT patients compared to controls; however, it didn't reach a statistical significance. Conclusions: The significantly higher levels of EMPs and PMPs in NTDT patients may contribute to the hypercoagulable state associated with the disease. Measurement of proB-type natriuretic peptide, though not statistically significant in this cohort, may hold potential as an early biomarker for pulmonary hypertension in NTDT patients, for which larger prospective studies are recommended.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.